Concepedia

Jiecan Zhou

JZ

Statistics

Publications

5

Citations

127

H-Index

5

Active since

2019

Affiliations

PharmacoGenetics (China)(Current)

University of South China

Xiangya Hospital Central South University

Central South University

First Affiliated Hospital of University of South China

Jiecan Zhou is an author at PharmacoGenetics (China) specializing in vascular endothelial growth factor, medicine, and hypertension pharmacotherapy.

ORCID

Publications per year

2019–2022

5

Publications

5

Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China

Zhefeng Zhong, Jia Huang, Xia Yang et al. · World Journal of Clinical Cases · 2020 · 49 citations · Full text

, , +14

Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes

Bao Sun, Fazhong He, Yongchao Gao et al. · Endocrine · 2019 · 29 citations

, , +12

Double Signal Amplification Strategy for Dual-Analyte Fluorescent Aptasensors for Visualizing Cancer Biomarker Proteins

Yanli Zhu, Jikai Wang, Haitao Xie et al. · Analytical Chemistry · 2022 · 20 citations

, , +17

RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial‐protective effects of metformin under high glucose in HUVECs

Jing Xu, Miao Liu, Muqiao Yu et al. · IUBMB Life · 2019 · 15 citations

, , +15

Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension

Jiecan Zhou, Fazhong He, Bao Sun et al. · Frontiers in Pharmacology · 2019 · 14 citations · Full text

, , +17

1–5 of 5